These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2815804)

  • 1. Hyperthermic perfusion with chemotherapy for melanoma of the extremities.
    Ghussen F; Krüger I; Smalley RV; Groth W
    World J Surg; 1989; 13(5):598-602. PubMed ID: 2815804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Randomized melanoma study of perfusion of the extremities. Results of treatment 2 1/2 years after premature discontinuation].
    Ghussen F; Krüger I; Groth W; Stützer H
    Chirurg; 1986 Oct; 57(10):619-23. PubMed ID: 3539548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma.
    Ghussen F; Krüger I; Groth W; Stützer H
    Cancer; 1988 Feb; 61(4):654-9. PubMed ID: 3276384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermic perfusion in malignant melanoma: 5-year results.
    Tonak J; Hohenberger W; Weidner F; Göhl H
    Recent Results Cancer Res; 1983; 86():229-38. PubMed ID: 6648004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized study of regional extremity perfusion in patients with malignant melanoma.
    Ghussen F; Nagel K; Groth W; Müller JM; Stützer H
    Ann Surg; 1984 Dec; 200(6):764-8. PubMed ID: 6508407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.
    Hafström L; Rudenstam CM; Blomquist E; Ingvar C; Jönsson PE; Lagerlöf B; Lindholm C; Ringborg U; Westman G; Ostrup L
    J Clin Oncol; 1991 Dec; 9(12):2091-4. PubMed ID: 1960549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective regression of unexcised melanoma in-transit metastases after hyperthermic isolation perfusion of the limbs with melphalan.
    Lejeune FJ; Deloof T; Ewalenko P; Fruhling J; Jabri M; Mathieu M; Nogaret JM; Verhest A
    Recent Results Cancer Res; 1983; 86():268-76. PubMed ID: 6648008
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of regional hyperthermic perfusion for primary and recurrent melanomas of the extremities.
    Jönsson PE; Hafström L; Hugander A
    Recent Results Cancer Res; 1983; 86():277-82. PubMed ID: 6648009
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Technique and results of hyperthermic perfusion of the extremity in melanoma patients].
    Omlor G; Bahmer F; Meessen S; Zang D; Feifel G; Zaun H
    Langenbecks Arch Chir; 1993; 378(1):21-5. PubMed ID: 8437498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthermic regional perfusion for melanoma and sarcoma of the limbs.
    Fraker DL
    Curr Probl Surg; 1999 Nov; 36(11):841-907. PubMed ID: 10569114
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperthermic perfusion of recurrent malignant melanoma on the extremities.
    Hafström L; Jönsson PE
    Acta Chir Scand; 1980; 146(5):313-8. PubMed ID: 7468061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperthermic-antiblastic perfusion in the treatment of tumor of the extremities].
    Di Filippo F; Cavaliere F; Anzà M; Garinei R; Rossi CR; Deraco M; Perri P; Botti C; Cigna E
    Suppl Tumori; 2002; 1(3):S35-7. PubMed ID: 12415785
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs.
    Thompson JF; Gianoutsos MP
    World J Surg; 1992; 16(2):227-33. PubMed ID: 1561803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-blastic hyperthermic perfusion in the treatment of melanoma of the extremities in the loco-regional diffusion phase].
    Di Filippo F; Garinei R; Anzà M; Cavaliere F; Botti C; Perri P; Di Filippo S
    Tumori; 2003; 89(4 Suppl):241-3. PubMed ID: 12903606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated regional limb hyperthermic perfusion as treatment for melanoma.
    Loescher LJ; Leigh S
    Cancer Nurs; 1984 Dec; 7(6):461-7. PubMed ID: 6568866
    [No Abstract]   [Full Text] [Related]  

  • 17. [Regional hyperthermic perfusion has impressive effect on manifest malignant melanoma].
    Hafström L
    Lakartidningen; 1992 Sep; 89(39):3189-90. PubMed ID: 1405932
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermic isolation limb perfusion for malignant melanoma: a review.
    Coit DG
    Cancer Invest; 1992; 10(4):277-84. PubMed ID: 1628227
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional morbidity of hyperthermic isolated regional perfusion of the extremities.
    Olieman AF; Schraffordt Koops H; Geertzen JH; Kingma H; Hoekstra HJ; Oldhoff J
    Ann Surg Oncol; 1994 Sep; 1(5):382-8. PubMed ID: 7850539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.